Steven J. Meyer
Financieel Directeur/CFO bij JVM Capital LLC
Actieve functies van Steven J. Meyer
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
JVM Capital LLC
JVM Capital LLC Investment ManagersFinance JVM Capital LLC provides investment advice. The private company is based in Oak Brook, IL and has subsidiaries in the United States. | Financieel Directeur/CFO | 04-08-2009 | - |
Jvm Realty Corp. | Chief Investment Officer | 04-04-2018 | - |
Financieel Directeur/CFO | 01-11-2005 | 04-04-2018 |
Loopbaan van Steven J. Meyer
Eerdere bekende functies van Steven J. Meyer
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
AKORN, INC. | Directeur/Bestuurslid | 01-06-2009 | 01-10-2020 |
Independent Dir/Board Member | 01-06-2009 | 01-10-2020 | |
INSYS THERAPEUTICS, INC. | Directeur/Bestuurslid | 13-05-2011 | 09-01-2017 |
Voorzitter | 09-01-2017 | 05-06-2019 | |
Independent Dir/Board Member | 16-05-2011 | 09-01-2017 | |
InSys Therapeutics, Inc. /Old/
InSys Therapeutics, Inc. /Old/ Pharmaceuticals: GenericHealth Technology InSys Therapeutics, Inc. is a pharmaceutical company that develops and seeks to commercialize innovative pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. The company's product pipeline targeting cancer-supportive care and cancer therapy that it believe can be developed cost efficiently and, if approved, commercialized through a targeted commercial organization. Its supportive care product candidates include Fentanyl SL Spray, a proprietary, fast-acting sublingual fentanyl spray for the treatment of breakthrough cancer pain, and its family of dronabinol product candidates for the treatment of chemotherapy-induced nausea and vomiting and appetite stimulation in AIDS patients. The company was founded by Dr. S. George Kottayil and John N. Kapoor on October 18, 2002 and is headquartered in Phoenix, AZ. | Directeur/Bestuurslid | 01-08-2007 | 02-05-2011 |
Insys Pharma, Inc. | Directeur/Bestuurslid | 01-08-2007 | 01-11-2010 |
BAXTER INTERNATIONAL INC. | Operationeel Directeur | 01-01-1997 | 01-07-2004 |
Treasurer | 01-07-2004 | 01-07-2004 |
Opleiding van Steven J. Meyer
Kellogg School of Management | Masters Business Admin |
University of Illinois At Urbana–Champaign | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 10 |
Operationeel
Director/Board Member | 4 |
Independent Dir/Board Member | 2 |
Director of Finance/CFO | 2 |
Sectoraal
Health Technology | 5 |
Finance | 3 |
Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
BAXTER INTERNATIONAL INC. | Health Technology |
Bedrijven in privébezit | 6 |
---|---|
Akorn, Inc.
Akorn, Inc. Pharmaceuticals: MajorHealth Technology Akorn, Inc. engages in the development, manufacture, and marketing of generic and prescription pharmaceuticals, and animal and consumer health products. It manufactures and markets branded and generic products including ophthalmic, injectable, oral liquids, topical, inhalants, and nasal sprays. The company was founded in 1971 and is headquartered in Lake Forest, IL. | Health Technology |
JVM Capital LLC
JVM Capital LLC Investment ManagersFinance JVM Capital LLC provides investment advice. The private company is based in Oak Brook, IL and has subsidiaries in the United States. | Finance |
InSys Therapeutics, Inc. /Old/
InSys Therapeutics, Inc. /Old/ Pharmaceuticals: GenericHealth Technology InSys Therapeutics, Inc. is a pharmaceutical company that develops and seeks to commercialize innovative pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. The company's product pipeline targeting cancer-supportive care and cancer therapy that it believe can be developed cost efficiently and, if approved, commercialized through a targeted commercial organization. Its supportive care product candidates include Fentanyl SL Spray, a proprietary, fast-acting sublingual fentanyl spray for the treatment of breakthrough cancer pain, and its family of dronabinol product candidates for the treatment of chemotherapy-induced nausea and vomiting and appetite stimulation in AIDS patients. The company was founded by Dr. S. George Kottayil and John N. Kapoor on October 18, 2002 and is headquartered in Phoenix, AZ. | Health Technology |
INSYS Therapeutics, Inc.
INSYS Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology INSYS Therapeutics, Inc. operates as a pharmaceutical company, which develops and commercializes supportive care products. It focuses on utilizing commercial pharmaceutical products that include Subsys, a proprietary sublingual fentanyl spray for BTCP in opioid-tolerant adult patients; and Syndros, a proprietary orally administered liquid formulation of dronabinol for the treatment of CINV and anorexia associated with weight loss in patients with AIDS. The company was founded by John N. Kapoor on June 15, 1990 and is headquartered in Chandler, AZ. | Health Technology |
Insys Pharma, Inc. | |
Jvm Realty Corp. | Finance |
- Beurs
- Insiders
- Steven J. Meyer
- Ervaring